| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |